2004

Haddow JE, Knight GJ, Palomaki GE, McClain MR, Pulkkinen AJ: The reference range and within-person variability of thyroid stimulating hormone (TSH) during the first and second trimesters of pregnancy.  J Med Screen, 11:170-174, 2004.

Lambert-Messerlian G, Halliday J, Williams J, Cain R, Msall ME, Palomaki GE, Canick JA: Effect of folic acid fortification on prevalence of neural tube defects in Rhode Island .  J Med Screen, 11:106-107, 2004.

McClain MR, Palomaki GE, Haddow JE: Is first trimester measurement of sex hormone binding globulin a possible screening test for gestational diabetes?  Am J Obstet Gynecol, 190:1808-1809, 2004.

Palomaki GE:  Prenatal screening for cystic fibrosis: An early report card (editorial).  Genet Med, 6:115, 2004.

Palomaki GE, FitzSimmons SC, Haddow JE: Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.  Genet Med, 6:405-414, 2004.

Palomaki GE, Knight GJ, Roberson MM, Cunningham GC, Lee JE, Strom CM, Pandian R:  Invasive trophoblastic antigen (hyperglycosylated human chorionic gonadotropin) in second-trimester maternal urine as a marker for Down syndrome: preliminary results of an observational study on fresh samples.  Clin Chem, 50:182-189, 2004.

Palomaki GE, Neveux LM, Knight GJ, Haddow JE, Pandian MR: Maternal serum invasive trophoblastic antigen (ITA) as a screening marker for Down syndrome during the second trimester.  Clin Chem, 50:1804-1808.

Pandian RJ, Cole LA, Palomaki GE:  Second-trimester maternal serum invasive trophoblast antigen: a marker for Down syndrome screening.  Clin Chem, 50:1433-1435, 2004.

Ritchie RF, Palomaki GE, Neveux LM, Naolotskaia O:  Reference distributions for complement proteins C3 and C4: a comparison of a large cohort to the world’s literature.  J Clin Lab Anal, 18:9-13, 2004.

Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TM, Craig WY: Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort.  J Clin Lab Anal, 18:1-8, 2004.

Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TM, Craig WY: Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.  J Clin Lab Anal, 18:139-152, 2004.

Ritchie RF, Palomaki GE, Neveux LM, Naolotskaia O:  Reference distributions for alpha2-macroglobulin: a comparison of a large cohort to the world’s literature.  J Clin Lab Anal, 18:148-152, 2004.

Ritchie RF, Palomaki GE: Selecting clinically relevant populations for reference intervals.  Clin Chem Lab Med, 42:702-709, 2004.

Watson MS, Cutting GR, Desnik RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW: Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.  Genet Med, 6:387-391, 2004.